This study seeks to elucidate the mechanistic pathways linking TMAO and resistin with obesity-induced vascular alterations and metabolic dysregulation, specifically focusing on their potential contributions to subclinical atherosclerosis, as indicated by CIMT, and the overall cardiometabolic risk profile in this population. The gene discussed is RETN; the disease is atherosclerosis.